GlassScriptPhysician profile
Jitesh Vinod Patel
NPI 1265640486
$9,982.21
in general payments reported to CMS, 2019-2025
50 companies · $2,258 in 2025
The $2,258 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,598 · 2020: $1,053 · 2021: $1,184 · 2022: $917 · 2023: $934 · 2024: $1,038 · 2025: $2,258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,800 · Travel and Lodging: $407 · Education: $23.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,800.09 |
| Travel and Lodging | $406.97 |
| Education | $23.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $942.83 | 2019-2020 | |
| Teleflex LLC | $916.71 | 2021-2025 | Urolift, Barrigel |
| Intuitive Surgical, INC. | $873.50 | 2019 | |
| Histosonics, INC. | $840.96 | 2025 | |
| Medtronic, INC. | $582.02 | 2021-2025 | Interstim, Altaviva |
| Dendreon Pharmaceuticals LLC | $555.94 | 2019-2025 | Provenge |
| Endo Pharmaceuticals INC. | $466.51 | 2019-2023 | Xiaflex |
| Boston Scientific Corporation | $408.71 | 2020-2025 | General - Oncology |
| Astellas Pharma US INC | $383.20 | 2019-2025 | Xtandi, Myrbetriq |
| Coloplast Corp | $380.79 | 2019-2025 | Porges Coloplast |
| Neotract INC. | $283.32 | 2019 | |
| Ambu INC. | $264.97 | 2021-2024 | |
| Pfizer INC. | $251.72 | 2019-2025 | |
| Janssen Biotech, INC. | $230.50 | 2022-2025 | Erleada, Akeega |
| Allergan, INC. | $217.29 | 2019-2022 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $186.22 | 2021 | |
| Sumitomo Pharma America, INC. | $182.53 | 2023-2025 | Orgovyx, Gemtesa |
| C. R. Bard, INC. & Subsidiaries | $174.77 | 2019-2020 | |
| Abbvie INC. | $157.49 | 2022-2025 | |
| Laborie Medical Technologies Corp. | $146.87 | 2024-2025 | Endosheath Technology, Optilume Bph Drug Coated Balloon Catheter |
| Blue Earth Diagnostics | $145.57 | 2019-2023 | |
| Ethicon US, LLC | $131.61 | 2019-2025 | Vistaseal, Surgiflo Hemostatic Matrix, Surgicel Nu-Knit |
| Metuchen Pharmaceuticals | $121.09 | 2020 | |
| Accord Healthcare, INC. | $107.35 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.82 | 2021 | |
| Procept Biorobotics Corporation | $93.35 | 2024-2025 | Aquabeam System |
| Merck Sharp & Dohme LLC | $79.74 | 2022-2025 | Keytruda, Lynparza |
| Sun Pharmaceutical Industries INC. | $66.39 | 2022-2024 | |
| Antares Pharma, INC. | $66.24 | 2022-2024 | Xyosted |
| Tempus Ai, INC | $53.24 | 2025 | Xt Cdx |
| Myriad Genetic Laboratories, INC. | $47.22 | 2021-2022 | |
| Myovant Sciences INC. | $47.10 | 2022 | |
| Novartis Pharmaceuticals Corporation | $46.72 | 2025 | |
| Amgen INC. | $42.49 | 2019 | |
| Urogen Pharma, INC. | $39.60 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.60 | 2022-2024 | |
| Travere Therapeutics, INC. | $32.53 | 2019-2021 | |
| Olympus America INC. | $29.33 | 2020-2024 | Itind System |
| Civco Medical Instruments | $27.30 | 2025 | |
| Baxter Healthcare | $26.77 | 2023 | Tisseel |
| Ferring Pharmaceuticals INC. | $26.26 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $23.76 | 2022 | |
| Tolmar, INC. | $23.40 | 2023 | |
| Verity Pharmaceuticals INC. | $22.02 | 2025 | Tlando |
| Halozyme INC | $21.18 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $19.68 | 2021 | |
| Dentsply Ih Ab | $18.94 | 2025 | Lofric |
| Calyxo, INC. | $18.23 | 2024 | Cvac Aspiration System |
| Urovant Sciences INC | $17.31 | 2022 | |
| Valencia Technologies Corporation | $7.52 | 2025 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jitesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.